Found: 9
Select item for more details and to access through your institution.
Distinct immune characteristics distinguish hereditary and idiopathic chronic pancreatitis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.
- Published in:
- 2017
- By:
- Publication type:
- journal article
GPR15 in colon cancer development and anti-tumor immune responses.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1254307
- By:
- Publication type:
- Article
Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease.
- Published in:
- BMC Neurology, 2007, v. 7, p. 14, doi. 10.1186/1471-2377-7-14
- By:
- Publication type:
- Article
Dual action of apolipoprotein E-interacting HCCR-1 oncoprotein and its implication for breast cancer and obesity.
- Published in:
- Journal of Cellular & Molecular Medicine, 2009, v. 13, n. 9b, p. 3868, doi. 10.1111/j.1582-4934.2009.00652.x
- By:
- Publication type:
- Article
Supramolecular Hydrogels for Long-Term Bioengineered Stem Cell Therapy.
- Published in:
- Advanced Healthcare Materials, 2015, v. 4, n. 2, p. 237, doi. 10.1002/adhm.201400304
- By:
- Publication type:
- Article
HCCRBP-1 directly interacting with HCCR-1 induces tumorigenesis through P53 stabilization.
- Published in:
- International Journal of Cancer, 2008, v. 122, n. 3, p. 501, doi. 10.1002/ijc.23146
- By:
- Publication type:
- Article
Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 332, p. 1, doi. 10.1126/scitranslmed.aaf1725
- By:
- Publication type:
- Article
Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status.
- Published in:
- BMC Cancer, 2009, v. 9, p. 1, doi. 10.1186/1471-2407-9-51
- By:
- Publication type:
- Article